First Time Loading...

Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI

Watchlist Manager
Brainstorm Cell Therapeutics Inc Logo
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
Watchlist
Price: 0.5169 USD -3.8% Market Closed
Updated: May 29, 2024
BCLI
/
Cash Flow Statement
/
Net Issuance of Common Stock

Brainstorm Cell Therapeutics Inc
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Brainstorm Cell Therapeutics Inc
Net Issuance of Common Stock Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
Net Issuance of Common Stock
$18.3m
CAGR 3-Years
-31%
CAGR 5-Years
9%
CAGR 10-Years
19%
Abbvie Inc
NYSE:ABBV
Net Issuance of Common Stock
-$1.1B
CAGR 3-Years
-9%
CAGR 5-Years
37%
CAGR 10-Years
-18%
Gilead Sciences Inc
NASDAQ:GILD
Net Issuance of Common Stock
-$719m
CAGR 3-Years
-22%
CAGR 5-Years
22%
CAGR 10-Years
-2%
Amgen Inc
NASDAQ:AMGN
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Issuance of Common Stock
-$288.7m
CAGR 3-Years
15%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Issuance of Common Stock
-$473.2m
CAGR 3-Years
51%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Brainstorm Cell Therapeutics Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
18.3m USD

Based on the financial report for Mar 31, 2024, Brainstorm Cell Therapeutics Inc's Net Issuance of Common Stock amounts to 18.3m USD.

What is Brainstorm Cell Therapeutics Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
19%

Over the last year, the Net Issuance of Common Stock growth was 427%. The average annual Net Issuance of Common Stock growth rates for Brainstorm Cell Therapeutics Inc have been -31% over the past three years , 9% over the past five years , and 19% over the past ten years .

ALPHA SPREAD
Join more than 141,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.